{"id":1069,"date":"2021-12-14T18:22:45","date_gmt":"2021-12-14T17:22:45","guid":{"rendered":"https:\/\/biotechaustria.org\/?post_type=mitglieder&#038;p=1069"},"modified":"2021-12-14T18:23:03","modified_gmt":"2021-12-14T17:23:03","slug":"invios-gmbh","status":"publish","type":"mitglieder","link":"https:\/\/biotechaustria.org\/en\/mitglieder\/invios-gmbh\/","title":{"rendered":"invIOs GmbH"},"content":{"rendered":"<p>invIOs steht f\u00fcr Innovative Immuno-Oncology.\u00a0Wir sind Pioniere in der Erforschung und Entwicklung von Wirkstoffkandidaten f\u00fcr Zelltherapien, die auf neue Immun-Checkpoints abzielen, sowie in der Immunmodulation.<\/p>\n","protected":false},"featured_media":1070,"parent":0,"template":"","class_list":["post-1069","mitglieder","type-mitglieder","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/mitglieder\/1069","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/mitglieder"}],"about":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/types\/mitglieder"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/media\/1070"}],"wp:attachment":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/media?parent=1069"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}